Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
0.840
-0.136 (-13.79%)
Nov 21, 2024, 2:04 PM EST - Market open
Enlivex Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 18 | 50 | 72 | 115 | 121 | 87 | |
| Market Cap Growth | -39.24% | -30.73% | -36.72% | -5.58% | 39.92% | - | |
| Enterprise Value | -4 | 24 | 20 | 33 | 94 | 74 | |
| Last Close Price | 0.98 | 2.70 | 3.94 | 6.25 | 8.43 | 8.39 | |
| PB Ratio | 0.71 | 1.67 | 1.28 | 1.35 | 3.42 | 7.69 | |
| P/TBV Ratio | 1.04 | 1.67 | 1.28 | 1.35 | 3.42 | 7.69 | |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.09 | 0.07 | 0.02 | 0.04 | |
| Quick Ratio | 9.57 | 4.55 | 7.70 | 18.09 | 8.17 | 2.34 | |
| Current Ratio | 10.06 | 5.57 | 7.92 | 18.32 | 8.72 | 2.75 | |
| Return on Equity (ROE) | -61.17% | -66.88% | -43.78% | -24.01% | -50.56% | -88.61% | |
| Return on Assets (ROA) | -27.46% | -30.09% | -19.81% | -17.79% | -21.12% | -37.68% | |
| Return on Capital (ROIC) | -29.86% | -33.88% | -21.11% | -18.95% | -25.54% | -49.88% | |
| Earnings Yield | -115.64% | -57.89% | -42.84% | -12.63% | -9.74% | -10.82% | |
| FCF Yield | -88.79% | -47.31% | -44.24% | -16.73% | -9.91% | -8.34% | |
| Buyback Yield / Dilution | -2.08% | -0.98% | -3.00% | -35.62% | -52.25% | -146.47% | |
| Total Shareholder Return | -2.08% | -0.98% | -3.00% | -35.62% | -52.25% | -146.47% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.